Categories: AppArtificial IntelligenceCauseDataHealthTechITManagementMarketPlatformProduct
basys.ai - We are a digital platform for helping manage chronic diseases like diabetes using data science
Investors 4
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.08.2023 | Pre-Seed | $2.4M | - |
Mentions in press and media 5
| Date | Title | Description |
| 16.08.2023 | Harvard Startup basys.ai Closes $2.4 Million In Funding | basys.ai – a healthcare technology company co-founded by Harvard alumni Amber Nigam and Jie Sun in 2022 at Harvard University – announced the completion of its latest funding round, securing a total of $2.4 million in investments. This fund... |
| 11.08.2023 | Basys.ai Raises $2.4M in Pre-Seed Funding | Basys.ai, a Cambridge, MA-based healthtech startup, raised $2.4m in pre-seed funding.
The round was led by Nina Capital with participation from Eli Lilly’s Lilly Ventures, Mayo Clinic, Two Lanterns Venture Partners, Asset Management Venture... |
| 10.08.2023 | Basys.ai grabs $2.4M for its prior authorization tech powered by Mayo Clinic’s data | Prior authorization, a fancy term for your doctor needing to gain approval from your health insurance company before doing a medical procedure, has typically been a heavily manual process involving lots of steps, reviews and people having t... |
| 05.09.2022 | Two Harvard Students Revolutionize Diabetes Treatment On A Regular Basys | Long-term health management of metabolic and chronic diseases is the largest cost burden on the U.S. healthcare system. Basys.ai, founded by Amber Nigam and Jie Sun in June 2021, is a “B2B SaaS platform supporting clinical decision-making f... |
| - | basys.ai | “Home | basys.ai” |
Reviews 0
